Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Lymphoma

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 56 articles:
HTML format



Single Articles


    July 2021
  1. DE ROOS AJ, Schinasi LH, Miligi L, Cerhan JR, et al
    Occupational Insecticide Exposure and Risk of Non-Hodgkin Lymphoma: A Pooled Case-Control Study from the InterLymph Consortium.
    Int J Cancer. 2021 Jul 16. doi: 10.1002/ijc.33740.
    PubMed     Abstract available


    February 2021
  2. LIEBOW M, Larson MC, Thompson CA, Nowakowski GS, et al
    Aspirin and other nonsteroidal anti-inflammatory drugs, statins, and risk of non-Hodgkin lymphoma.
    Int J Cancer. 2021 Feb 28. doi: 10.1002/ijc.33541.
    PubMed     Abstract available


    November 2020
  3. JIANG S, Qin Y, Jiang H, Liu B, et al
    Molecular profiling of Chinese R-CHOP treated DLBCL patients: Identifying a high-risk subgroup.
    Int J Cancer. 2020;147:2611-2620.
    PubMed     Abstract available


    October 2020
  4. SABERI HOSNIJEH F, Casabonne D, Nieters A, Solans M, et al
    Association between anthropometry and lifestyle factors and risk of B cell lymphoma: an exposome wide analysis.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33369.
    PubMed     Abstract available


  5. ZHANG L, Wang Y, Li X, Li L, et al
    Radiotherapy vs sequential DDGP and radiotherapy in newly diagnosed early NK/T cell lymphoma: A randomized, controlled, open-label, multicenter study.
    Int J Cancer. 2020 Oct 9. doi: 10.1002/ijc.33329.
    PubMed     Abstract available


    August 2020
  6. KANE E, Painter D, Smith A, Lamb M, et al
    Risk of mature B-cell neoplasms and precursor conditions after joint replacement: A report from the Haematological Malignancy Research Network.
    Int J Cancer. 2020;147:702-708.
    PubMed     Abstract available


    July 2020
  7. ROIDER T, Wang X, Huttl K, Muller-Tidow C, et al
    The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
    Int J Cancer. 2020 Jul 7. doi: 10.1002/ijc.33202.
    PubMed     Abstract available


    June 2020
  8. KACHURI L, Beane Freeman LE, Spinelli JJ, Blair A, et al
    Insecticide use and risk of non-Hodgkin lymphoma subtypes: a subset meta-analysis of the North American Pooled Project.
    Int J Cancer. 2020 Jun 23. doi: 10.1002/ijc.33164.
    PubMed     Abstract available


  9. DEUBLER EL, Gapstur SM, Diver WR, Gaudet MM, et al
    Erythrocyte Levels of Cadmium and Lead and Risk of B-Cell Non-Hodgkin Lymphoma and Multiple Myeloma.
    Int J Cancer. 2020 Jun 7. doi: 10.1002/ijc.33136.
    PubMed     Abstract available


    April 2020
  10. LI M, Shen Y, Chen Y, Gao H, et al
    Characterization of hepatitis B virus infection and viral DNA integration in non-Hodgkin lymphoma.
    Int J Cancer. 2020 Apr 29. doi: 10.1002/ijc.33027.
    PubMed     Abstract available


    March 2020
  11. NAUDIN S, Solans Margalef M, Saberi Hosnijeh F, Nieters A, et al
    Healthy lifestyle and the risk of lymphoma in the EPIC study.
    Int J Cancer. 2020 Mar 16. doi: 10.1002/ijc.32977.
    PubMed     Abstract available


  12. TAJ T, Poulsen AH, Ketzel M, Geels C, et al
    Long-Term Exposure to Air Pollution and Risk of Non-Hodgkin lymphoma in Denmark: A Population-based Case-Control Study.
    Int J Cancer. 2020 Mar 16. doi: 10.1002/ijc.32978.
    PubMed     Abstract available


  13. DIETZ A, Dalda N, Zielke S, Dittmann J, et al
    Proteasome inhibitors and Smac mimetics cooperate to induce cell death in Diffuse Large B-cell Lymphoma by stabilizing NOXA and triggering mitochondrial apoptosis.
    Int J Cancer. 2020 Mar 13. doi: 10.1002/ijc.32976.
    PubMed     Abstract available


    January 2020
  14. TRICKEY A, May MT, Gill MJ, Grabar S, et al
    Cause-specific mortality after diagnosis of cancer among HIV-positive patients: a collaborative analysis of cohort studies.
    Int J Cancer. 2020 Jan 31. doi: 10.1002/ijc.32895.
    PubMed     Abstract available


    October 2019
  15. LIU Z, Jarrett RF, Hjalgrim H, Proietti C, et al
    Evaluation of the antibody response to the EBV proteome in EBV-associated classic Hodgkin lymphoma.
    Int J Cancer. 2019 Oct 16. doi: 10.1002/ijc.32741.
    PubMed     Abstract available


    September 2019
  16. CHONG Y, Liu Y, Lu S, Cai B, et al
    Critical individual roles of the BCR and FGFR1 kinase domains in BCR-FGFR1-driven stem cell leukemia/lymphoma syndrome.
    Int J Cancer. 2019 Sep 16. doi: 10.1002/ijc.32665.
    PubMed     Abstract available


  17. PURDUE MP, Lan Q, Langseth H, Grimsrud TK, et al
    Pre-diagnostic serum sCD27 and sCD30 in serial samples and risks of non-Hodgkin lymphoma subtypes.
    Int J Cancer. 2019 Sep 15. doi: 10.1002/ijc.32684.
    PubMed     Abstract available


    May 2019
  18. PARODI S, Seniori Costantini A, Crosignani P, Fontana A, et al
    Childhood infectious diseases and risk of non-Hodgkin's lymphoma according to the WHO classification: a reanalysis of the Italian multicentre case-control study.
    Int J Cancer. 2019 May 11. doi: 10.1002/ijc.32393.
    PubMed     Abstract available


  19. PEPRAH S, Ogwang MD, Kerchan P, Reynolds SJ, et al
    Risk factors for Burkitt lymphoma in East African children and minors: a case-control study in malaria-endemic regions in Uganda, Tanzania, and Kenya.
    Int J Cancer. 2019 May 4. doi: 10.1002/ijc.32390.
    PubMed     Abstract available


  20. CHATTOPADHYAY S, Zheng G, Sud A, Sundquist K, et al
    Second primary cancers in non-Hodgkin lymphoma: family history and survival.
    Int J Cancer. 2019 May 4. doi: 10.1002/ijc.32391.
    PubMed     Abstract available


  21. MAGUIRE A, Chen X, Wisner L, Malasi S, et al
    Enhanced DNA repair and genomic stability identify a novel HIV related Diffuse Large B-cell Lymphoma signature.
    Int J Cancer. 2019 May 1. doi: 10.1002/ijc.32381.
    PubMed     Abstract available


    April 2019
  22. BASSIG BA, Shu XO, Sjodin A, Koh WP, et al
    Pre-diagnostic blood levels of organochlorines and risk of non-Hodgkin lymphoma in three prospective cohorts in China and Singapore.
    Int J Cancer. 2019 Apr 19. doi: 10.1002/ijc.32350.
    PubMed     Abstract available


  23. PARK LC, Song YJ, Kim DJ, Kim MJ, et al
    The effects of erythropoiesis-stimulating agents on the management of chemotherapy-induced anemia and tumor growth in diffuse large B-cell lymphoma patients.
    Int J Cancer. 2019 Apr 11. doi: 10.1002/ijc.32328.
    PubMed     Abstract available


    January 2019
  24. WEIBULL CE, Bjorkholm M, Glimelius I, Lambert PC, et al
    Temporal trends in treatment-related incidence of diseases of the circulatory system among Hodgkin lymphoma patients.
    Int J Cancer. 2019 Jan 21. doi: 10.1002/ijc.32142.
    PubMed     Abstract available


  25. WANG X, Zhang T, Song Z, Li L, et al
    Tumor CD73/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: Correlations with clinicopathological characteristics and clinical outcome.
    Int J Cancer. 2019 Jan 21. doi: 10.1002/ijc.32144.
    PubMed     Abstract available


    December 2018
  26. SOLANS M, Benavente Y, Saez M, Agudo A, et al
    Adherence to the Mediterranean diet and lymphoma risk in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2018 Dec 26. doi: 10.1002/ijc.32091.
    PubMed     Abstract available


    November 2018
  27. JOKO-FRU WY, Parkin DM, Borok M, Chokunonga E, et al
    Survival from childhood cancers in Eastern Africa: A population-based registry study.
    Int J Cancer. 2018;143:2409-2415.
    PubMed     Abstract available


    October 2018
  28. SUBRAMANIAN K, Dierckx T, Khouri R, Menezes SM, et al
    Decreased RORC expression and downstream signaling in HTLV-1-associated Adult T-cell Lymphoma/Leukemia uncovers an antiproliferative IL17 link: a potential target for immunotherapy?
    Int J Cancer. 2018 Oct 10. doi: 10.1002/ijc.31922.
    PubMed     Abstract available


    September 2018
  29. DAVIS JM, Garb Y
    A strong spatial association between e-waste burn sites and childhood lymphoma in the West Bank, Palestine.
    Int J Cancer. 2018 Sep 27. doi: 10.1002/ijc.31902.
    PubMed     Abstract available


  30. CHATTOPADHYAY S, Sud A, Zheng G, Yu H, et al
    Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.
    Int J Cancer. 2018 Sep 21. doi: 10.1002/ijc.31801.
    PubMed     Abstract available


  31. PURDUE MP, Lan Q, Hoffman-Bolton J, Hildesheim A, et al
    Circulating sCD27 and sCD30 in pre-diagnostic samples collected fifteen years apart and future non-Hodgkin lymphoma risk.
    Int J Cancer. 2018 Sep 19. doi: 10.1002/ijc.31879.
    PubMed     Abstract available


    August 2018
  32. YE X, Zhang G, Righolt C, Johnston JB, et al
    Associations between statin use and risk of non-Hodgkin lymphomas by subtype.
    Int J Cancer. 2018;143:971-979.
    PubMed     Abstract available


    May 2018
  33. CHIU YH, Bertrand KA, Zhang S, Laden F, et al
    A prospective analysis of circulating saturated and monounsaturated fatty acids and risk of non-Hodgkin lymphoma.
    Int J Cancer. 2018 May 14. doi: 10.1002/ijc.31602.
    PubMed     Abstract available


  34. GAO R, Liang JH, Wang L, Zhu HY, et al
    Low Serum Cholesterol Levels Predict Inferior Prognosis and Improve NCCN-IPI Scoring in Diffuse Large B Cell Lymphoma.
    Int J Cancer. 2018 May 9. doi: 10.1002/ijc.31590.
    PubMed     Abstract available


    April 2018
  35. BANDAPALLI OR, Paramasivam N, Giangiobbe S, Kumar A, et al
    Whole genome sequencing reveals DICER1 as a candidate predisposing gene in familial Hodgkin lymphoma.
    Int J Cancer. 2018 Apr 30. doi: 10.1002/ijc.31576.
    PubMed    


  36. VERMEULEN R, Saberi Hosnijeh F, Bodinier B, Portengen L, et al
    Pre-diagnostic blood immune markers, incidence and progression of B-cell lymphoma and multiple myeloma; univariate and functionally-informed multivariate analyses.
    Int J Cancer. 2018 Apr 18. doi: 10.1002/ijc.31536.
    PubMed     Abstract available


  37. MPUNGA T, Znaor A, Uwizeye FR, Uwase A, et al
    A case-control study of HIV infection and cancer in the era of antiretroviral therapy in Rwanda.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31537.
    PubMed     Abstract available


  38. RAASCHOU-NIELSEN O, Hvidtfeldt U, Roswall N, Hertel O, et al
    Ambient benzene at the residence and risk for subtypes of childhood leukaemia, lymphoma and CNS tumour.
    Int J Cancer. 2018 Apr 6. doi: 10.1002/ijc.31421.
    PubMed     Abstract available


    March 2018
  39. CALIP GS, Patel PR, Adimadhyam S, Xing S, et al
    Tumor necrosis factor-alpha inhibitors and risk of non-Hodgkin lymphoma in a cohort of adults with rheumatologic conditions.
    Int J Cancer. 2018 Mar 30. doi: 10.1002/ijc.31407.
    PubMed     Abstract available


  40. BASSIG BA, Willhauck-Fleckenstein M, Shu XO, Koh WP, et al
    Serologic markers of viral infection and risk of non-Hodgkin lymphoma: A pooled study of three prospective cohorts in China and Singapore.
    Int J Cancer. 2018 Mar 25. doi: 10.1002/ijc.31385.
    PubMed     Abstract available


    November 2017
  41. COWELL JK, Qin H, Hu T, Wu Q, et al
    Mutation in the FGFR1 tyrosine kinase domain or inactivation of PTEN is associated with acquired resistance to FGFR inhibitors in FGFR1-driven leukemia/lymphomas.
    Int J Cancer. 2017;141:1822-1829.
    PubMed     Abstract available


    October 2017
  42. JAYASEKARA H, Juneja S, Hodge AM, Room R, et al
    Lifetime alcohol intake and risk of non-Hodgkin lymphoma: Findings from the Melbourne Collaborative Cohort Study.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31123.
    PubMed     Abstract available


  43. MAWSON AR, Majumdar S
    Malaria, Epstein-Barr virus, vitamin A, and Burkitt's lymphoma: Response to Joob and Wiwanitkit.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31122.
    PubMed    


  44. JOOB B, Wiwanitkit V
    Malaria, Epstein-Barr virus, vitamin A and Burkitt's lymphoma.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31118.
    PubMed    


  45. HOSRY J, Miranda RN, Samaniego F, Economides MP, et al
    Clinicopathologic Characteristics and Outcomes of Transformed Diffuse Large B-Cell Lymphoma in Hepatitis C Virus-Infected Patients.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31110.
    PubMed     Abstract available


  46. BIASOLI I, Castro N, Delamain M, Silveira T, et al
    Lower socioeconomic status is independently associated with shorter survival in Hodgkin Lymphoma patients - an analysis from the Brazilian Hodgkin Lymphoma Registry.
    Int J Cancer. 2017 Oct 11. doi: 10.1002/ijc.31096.
    PubMed     Abstract available


    September 2017
  47. LI J, Wang X, Xie Y, Ying Z, et al
    The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma.
    Int J Cancer. 2017 Sep 14. doi: 10.1002/ijc.31044.
    PubMed     Abstract available


    August 2017
  48. CHASIMPHA SJD, Parkin DM, Masamba L, Dzamalala CP, et al
    Three-year cancer incidence in Blantyre, Malawi (2008-2010).
    Int J Cancer. 2017;141:694-700.
    PubMed     Abstract available


  49. JOCHEMS C, Hodge JW, Fantini M, Tsang KY, et al
    ADCC employing an NK cell line (haNK) expressing the high affinity CD16 allele with avelumab, an anti-PD-L1 antibody.
    Int J Cancer. 2017;141:583-593.
    PubMed     Abstract available


    July 2017
  50. MAWSON AR, Majumdar S
    Malaria, Epstein-Barr virus infection, and the Pathogenesis of Burkitt's Lymphoma.
    Int J Cancer. 2017 Jul 13. doi: 10.1002/ijc.30885.
    PubMed     Abstract available


    June 2017
  51. ZENZ T, Kreuz M, Fuge M, Klapper W, et al
    TP53 mutation and survival in aggressive B cell lymphoma.
    Int J Cancer. 2017 Jun 14. doi: 10.1002/ijc.30838.
    PubMed     Abstract available


    May 2017
  52. JANKET SJ, Ackerson LK, Meurman JH
    Potential reverse causation?
    Int J Cancer. 2017;140:2168.
    PubMed    


    April 2017
  53. HAVERKOS BM, Huang Y, Gru A, Pancholi P, et al
    Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas.
    Int J Cancer. 2017;140:1899-1906.
    PubMed     Abstract available


    March 2017
  54. SHETZER Y, Napchan Y, Kaufman T, Molchadsky A, et al
    Immune deficiency augments the prevalence of p53 loss of heterozygosity in spontaneous tumors but not bi-directional loss of heterozygosity in bone marrow progenitors.
    Int J Cancer. 2017;140:1364-1369.
    PubMed     Abstract available


    November 2016
  55. ROTTENBERG Y, Levine H, Keinan-Boker L, Derazne E, et al
    Risk of nasopharyngeal carcinoma penetrates across immigrant generations: A migrant cohort study of 2.3 million Jewish Israeli adolescents.
    Int J Cancer. 2016 Nov 16. doi: 10.1002/ijc.30525.
    PubMed     Abstract available


    August 2016
  56. HALABI MA, Jaccard A, Moulinas R, Bahri R, et al
    Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment.
    Int J Cancer. 2016;139:793-802.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: